by Stren & Blan Partners | Dec 31, 2025 | Health and Pharmaceutical, Insight
Q4 2025 marks an important period for Nigeria’s health and pharmaceutical sector. It is no longer just about introducing new reforms, but about strengthening what has already been put in place, expanding it, and earning global confidence.While Q3 focused on setting up...
by Stren & Blan Partners | Nov 24, 2025 | Health and Pharmaceutical, Insight
Nigeria’s shift from a voluntary health insurance scheme to a mandatory national system under the National Health Insurance Authority (NHIA) Act represents one of the most consequential transformations in the country’s healthcare financing landscape. For decades, the...
by Stren & Blan Partners | Oct 14, 2025 | Health and Pharmaceutical, Insight
The third quarter of 2025 was a notable period in Nigeria’s health and pharmaceutical trajectory, characterised by a sequence of reforms designed to enhance structural efficiency and restore investor confidence. Central to this evolving transformation was the...
by Stren & Blan Partners | Sep 18, 2025 | Health and Pharmaceutical, Insight
Public-Private Partnerships (PPPs) are becoming an increasingly important mechanism for financing, building, and operating healthcare infrastructure and services in Nigeria. With government budgets stretched and demand for quality healthcare rising, PPPs offer a way...
by Stren & Blan Partners | Sep 4, 2025 | Health and Pharmaceutical, Insight
The advent of telemedicine has redefined healthcare delivery globally, and Nigeria is no exception. Telemedicine emerged as a result of technological advancements and its increasing integration into daily life. It involves the use of telecommunications and digital...
by Stren & Blan Partners | Jul 21, 2025 | Health and Pharmaceutical, Insight
The second quarter of 2025 marked a dynamic phase in Nigeria’s health sector, defined by reforms in pharmaceutical manufacturing, international collaboration, and stringent regulatory enforcement. The Federal Government announced a two-year exemption on import duty...
